The Alzheimer's disease mitochondrial cascade hypothesis.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic theory paper with no new human data
PubMed 20442494 · doi:10.3233/JAD-2010-100339
What was done
This is a narrative review and theoretical perspective paper outlining the mitochondrial cascade hypothesis of sporadic Alzheimer's disease (AD). The authors synthesize literature examining how inherited baseline mitochondrial durability interacts with aging to trigger hallmark AD pathologies, such as tau phosphorylation and amyloid-beta amyloidosis.
What was found
The abstract reports no numerical or quantitative data. It narratively highlights lines of evidence supporting the hypothesis, such as endophenotype studies suggesting a maternal genetic component and the limited clinical efficacy observed with amyloid-reducing therapies.
Why it matters
It offers an alternative conceptual framework prioritizing mitochondrial dysfunction as the primary driver of late-onset sporadic AD, directing focus toward novel upstream therapeutic targets.
Limits
The abstract describes a narrative theory and review paper presenting no new primary empirical data, quantitative meta-analyses, or systematic review methodology.
Cited by
- context The majority of dementia cases are caused by mitochondrial dysfunction rather than rare inherited genetic mutations.